213 related articles for article (PubMed ID: 22049531)
1. MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer.
Hirata H; Hinoda Y; Ueno K; Shahryari V; Tabatabai ZL; Dahiya R
Carcinogenesis; 2012 Jan; 33(1):41-8. PubMed ID: 22049531
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer.
Hirata H; Hinoda Y; Ueno K; Nakajima K; Ishii N; Dahiya R
Carcinogenesis; 2012 Mar; 33(3):501-8. PubMed ID: 22180573
[TBL] [Abstract][Full Text] [Related]
3. The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster.
Itesako T; Seki N; Yoshino H; Chiyomaru T; Yamasaki T; Hidaka H; Yonezawa T; Nohata N; Kinoshita T; Nakagawa M; Enokida H
PLoS One; 2014; 9(2):e84311. PubMed ID: 24520312
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppressor microRNA-493 decreases cell motility and migration ability in human bladder cancer cells by downregulating RhoC and FZD4.
Ueno K; Hirata H; Majid S; Yamamura S; Shahryari V; Tabatabai ZL; Hinoda Y; Dahiya R
Mol Cancer Ther; 2012 Jan; 11(1):244-53. PubMed ID: 22057916
[TBL] [Abstract][Full Text] [Related]
5. Tumor-suppressor microRNA-139-5p restrains bladder cancer cell line ECV-304 properties via targeting Connexin 43.
Chi Q; Wang ZY; Li HY; Song DB; Xu H; Ma G; Wang ZM; Li XM
Chin Med J (Engl); 2019 Oct; 132(19):2354-2361. PubMed ID: 31567382
[TBL] [Abstract][Full Text] [Related]
6. Effects of microRNA-135a on the epithelial-mesenchymal transition, migration and invasion of bladder cancer cells by targeting GSK3β through the Wnt/β-catenin signaling pathway.
Mao XW; Xiao JQ; Li ZY; Zheng YC; Zhang N
Exp Mol Med; 2018 Jan; 50(1):e429. PubMed ID: 29350680
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA DLX6-AS1 facilitates bladder cancer progression through modulating miR-195-5p/VEGFA signaling pathway.
Wang H; Niu X; Jiang H; Mao F; Zhong B; Jiang X; Fu G
Aging (Albany NY); 2020 Aug; 12(16):16021-16034. PubMed ID: 32756011
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA SNHG16 contributes to the development of bladder cancer via regulating miR-98/STAT3/Wnt/β-catenin pathway axis.
Feng F; Chen A; Huang J; Xia Q; Chen Y; Jin X
J Cell Biochem; 2018 Nov; 119(11):9408-9418. PubMed ID: 30132983
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer.
Hirata H; Ueno K; Shahryari V; Tanaka Y; Tabatabai ZL; Hinoda Y; Dahiya R
PLoS One; 2012; 7(11):e51056. PubMed ID: 23226455
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
[TBL] [Abstract][Full Text] [Related]
11. Circ_0058063 regulates CDK6 to promote bladder cancer progression by sponging miR-145-5p.
Sun M; Zhao W; Chen Z; Li M; Li S; Wu B; Bu R
J Cell Physiol; 2019 Apr; 234(4):4812-4824. PubMed ID: 30362519
[TBL] [Abstract][Full Text] [Related]
12. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
Kong LY; Xue M; Zhang QC; Su CF
Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-940 Targets INPP4A or GSK3β and Activates the Wnt/β-Catenin Pathway to Regulate the Malignant Behavior of Bladder Cancer Cells.
Wang R; Wu Y; Huang W; Chen W
Oncol Res; 2018 Jan; 26(1):145-155. PubMed ID: 28337959
[TBL] [Abstract][Full Text] [Related]
14. MiR-101 promotes nasopharyngeal carcinoma cell apoptosis through inhibiting Ras/Raf/MEK/ERK signaling pathway.
Wu RS; Qiu EH; Zhu JJ; Wang JR; Lin HL
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):150-157. PubMed ID: 29364482
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA PEG10 facilitates bladder cancer cells proliferation, migration, and invasion via repressing microRNA-29b.
Liang T; Wang Y; Wang Y; Wang Y
J Cell Physiol; 2019 Nov; 234(11):19740-19749. PubMed ID: 30941768
[TBL] [Abstract][Full Text] [Related]
16. Increased miR-323a induces bladder cancer cell apoptosis by suppressing c-Met.
Qiu J; Zeng FR; Fang Y; Li J; Xiao SY
Kaohsiung J Med Sci; 2019 Sep; 35(9):542-549. PubMed ID: 31180621
[TBL] [Abstract][Full Text] [Related]
17. Target inhibition on GSK-3β by miR-9 to modulate proliferation and apoptosis of bladder cancer cells.
Dong ZC; Zhang D; Wang SB; Lin ZQ
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3018-3026. PubMed ID: 29863246
[TBL] [Abstract][Full Text] [Related]
18. MiR-194-5p inhibits cell migration and invasion in bladder cancer by targeting E2F3.
Wang Y; Sun G; Wang C; Guo W; Tang Q; Wang M
J BUON; 2018; 23(5):1492-1499. PubMed ID: 30570877
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of microRNA-340 promotes osteosarcoma cell apoptosis while suppressing proliferation, migration, and invasion by inactivating the CTNNB1-mediated Notch signaling pathway.
Pan BL; Wu L; Pan L; Yang YX; Li HH; Dai YJ; He ZQ; Tan L; Huang YG; Tong ZW; Liao JL
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29769415
[TBL] [Abstract][Full Text] [Related]
20. miR-101 suppresses vascular endothelial growth factor C that inhibits migration and invasion and enhances cisplatin chemosensitivity of bladder cancer cells.
Lei Y; Li B; Tong S; Qi L; Hu X; Cui Y; Li Z; He W; Zu X; Wang Z; Chen M
PLoS One; 2015; 10(2):e0117809. PubMed ID: 25658842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
